Announcement to marketing authorisation holders Under an amendment to the Health Insurance Act that entered into force at the beginning of 2025, the reasonable wholesale ... Read more
The application instructions have been updated on March 28, 2025. The update clarifies the instructions for submitting sources. From now on, all sources must be ... Read more
Based on an amendment to the Health Insurance Act that entered into force at the beginning of 2025, the confirmed reasonable wholesale prices of reimbursable ... Read more
Based on the amendment of the Health Insurance Act that enters into force on 1 January 2025 (given 19 December 2024) the confirmed reasonable wholesale ... Read more
Announcement to marketing authorisation holders Based on the amendment of the Health Insurance Act that enters into force on 1 January 2025 (given 19 December ... Read more
Substitution for biologic medicines will be expanded to cover the following products: Starting 1 April 2024, enoxaparin products and all other low molecular weight heparins ... Read more
From 1 March 2023, decisions of the Pharmaceuticals Pricing Board will be appealed against to the Helsinki Administrative Court. By this change, the procedure for ... Read more
Starting 1 April 2023, a wider selection of inhaled medicinal products will become eligible for substitution. At the same time, packages that contain a delivery ... Read more
Pharmaceuticals Pricing Board (HILA), Finnish Medicines Agency (Fimea), Social Insurance Institution (KELA) and Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) organize a hearing on ... Read more
The Finnish government agencies have tendered electronic invoice service provider. At this time Posti Messaging/OpusCapita is the Finnish Government’s electronic invoicing service provider and Finnish ... Read more
The new email address is hila.stm(at)gov.fi Messages sent to the old address will still reach their recipients for two years, but all messages sent from ... Read more